Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
289.6 INR | +3.37% | +8.38% | +16.00% |
Apr. 18 | India's Biocon developing its own version of Wegovy, clinical trial likely next year | RE |
Apr. 18 | Biocon Signs Licensing and Supply Pact with Biomm to Commercialize Generic Ozempic in Brazil | MT |
Evolution of the average Target Price on Biocon Limited
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Biocon Limited
Jefferies & Co. |
EPS Revisions
- Stock Market
- Equities
- BIOCON Stock
- Consensus Biocon Limited